This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,659 Years Active: 1987
Title: Innovations of Johannes Hartenstein
Introduction
Johannes Hartenstein is a notable inventor based in Stegen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of blood vessel diseases. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Hartenstein holds a patent for 1-6-naphthyridine derivatives, which are described as useful in the treatment of blood vessel diseases. The patent outlines the general formula for these derivatives, where R¹ can be an unsubstituted or substituted aromatic or heteroaromatic ring. R² is defined as a straight-chained or branched alkyl radical containing up to four carbon atoms or a benzyl radical. R³ can be a hydrogen atom, a straight-chained or branched alkyl radical, or an alkoxycarbonyl radical containing up to four carbon atoms. R⁴ is a straight-chained or branched alkyl radical containing up to four carbons, while R⁵ is a carbonyl group or a straight-chained, branched, or cyclic alkoxycarbonyl radical containing up to 17 carbon atoms, which may also include an oxygen, sulfur, or nitrogen atom. The patent also covers pharmacologically acceptable salts of these compounds.
Career Highlights
Throughout his career, Johannes Hartenstein has focused on innovative research that bridges chemistry and medicine. His work has not only contributed to the scientific community but has also provided potential therapeutic solutions for patients suffering from vascular diseases. His patent reflects a commitment to improving health outcomes through scientific innovation.
Collaborations
Hartenstein has collaborated with notable colleagues, including Jurgen Kleinschroth and Hartmut Osswald. These partnerships have likely enhanced the research and development process, leading to more robust and effective solutions in the field of pharmaceuticals.
Conclusion
Johannes Hartenstein's contributions to the field of medicine through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work on 1-6-naphthyridine derivatives is a testament to the impact that dedicated inventors can have on improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile